The reductions in heart attack and stroke risk13%, 20%, 26% across different trialsare striking in their own right
Currently, public perception has led to GLP-1s being requested as that solution
Call Us to Boost Your Heart Health Semaglutide and tirzepatide represent front-line options in the fight against obesity and type 2 diabetes
The goal is consistency, not perfection
In clinical trials of sermorelin in GH-deficient adults, IGF-1 levels increased significantly with nightly subcutaneous dosing over weeks to months
A 2021 study published in Diabetes Care (the ELAD trial) found that liraglutide was associated with slower decline in cerebral glucose metabolism in patients with Alzheimer's disease, as measured by FDG-PET imaging, though clinical outcome measures showed mixed results